The use of plaque score measurements to assess changes in atherosclerotic plaque burden induced by lipid-lowering therapy over time: The METEOR study

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 9, 2011, Pages 784-795

  Peters, Sanne A E ^a   Dogan, Soner ^a,b   Meijer, Rudy ^c   Palmer, Mike K ^d   Grobbee, Diederick E ^a   Crouse III, John R ^e   O'Leary, Daniel H ^f   Evans, Gregory W ^e   Raichlen, Joel S ^g   Bots, Michiel L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Altrecht   (Netherlands)

^c Bio Clinica   (Netherlands)

^d KEELE UNIVERSITY   (United Kingdom)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f Carney Hospital   (United States)

^g ASTRAZENECA   (United Kingdom)

Author keywords

Atherosclerosis; B mode ultrasound; Clinical trial; Plaque score; Statin

Indexed keywords

ROSUVASTATIN;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ULTRASOUND;

AGED; ATHEROSCLEROSIS; CAROTID ARTERIES; FEMALE; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PLACEBOS; PYRIMIDINES; REPRODUCIBILITY OF RESULTS; SULFONAMIDES;

EID: 80053197815     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.8169     Document Type: Article

References (37)

1. Revkin JH, Shear CL, Pouleur HG, Ryder SW, Orloff DG: Biomarkers in the prevention and treatment of atherosclerosis: need, validation, and future. Pharmacol Rev, 2007; 59: 40-53
2. Bots ML, Evans GW, Riley WA, Grobbee DE: Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke, 2003; 34: 2985-2994
3. Espeland MA, O'Leary DH, Terry JG, Morgan T, Evans G, Mudra H: Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMGCoA reductase inhibitors. Curr Control Trials Cardiovasc Med, 2005; 6: 3
4. Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, Dhanjil S, Griffin M, Belcaro G, Rumley A, Lowe GD: Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke, 1999; 30: 841-850
5. Held C, Hjemdahl P, Eriksson SV, Bjorkander I, Forslund L, Rehnqvist N: Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J, 2001; 22: 62-72
6. Hollander M, Bots ML, Del Sol AI, Koudstaal PJ, Witteman JC, Grobbee DE, Hofman A, Breteler MM: Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation, 2002; 105: 2872-2877
7. Johnsen SH, Mathiesen EB, Joakimsen O, Stensland E, Wilsgaard T, Løchen ML, Njølstad I, Arnesen E: Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromso Study. Stroke, 2007; 38: 2873-2880
8. Kitamura A, Iso H, Imano H. Ohira T, Okada T, Sato S, Kiyama M, Tanigawa T, Yamagishi K, Shimamoto T: Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men. Stroke, 2004; 35: 2788-2794
9. Nagai Y, Kitagawa K, Sakaguchi M, Shimizu Y, Hashimoto H, Yamagami H, Narita M, Ohtsuki T, Hori M, Matsumoto M: Significance of earlier carotid atherosclerosis for stroke subtypes. Stroke, 2001; 32: 1780-1785
10. Rothwell PM: Carotid artery disease and the risk of ischaemic stroke and coronary vascular events. Cerebrovasc Dis, 2000; 10 Suppl 5: 21-33
11. Salonen JT, Salonen R: Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb, 1991; 11: 1245-1249
12. Stork S, van den Beld AW, von Schacky C, Angermann CE, Lamberts SW, Grobbee DE, Bots ML: Carotid artery plaque burden, stiffness, and mortality risk in elderly men: a prospective, population-based cohort study. Circulation, 2004; 110: 344-348
13. Touboul PJ, Labreuche J, Vicaut E, Amarenco P: Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke, 2005; 36: 1741-1745
14. Ohnishi H, Sawayama Y, Furusyo N, Maeda S, Tokunaga S, Hayashi J: Risk factors for and the prevalence of peripheral arterial disease and its relationship to carotid atherosclerosis: the Kyushu and Okinawa Population Study (KOPS). J Atheroscler Thromb, 2010; 17: 751-758
15. Yamagishi T, Kato M, Koiwa Y, Hasegawa H, Kanai H: Impact of lifestyle-related diseases on carotid arterial wall elasticity as evaluated by an ultrasonic phased-tracking method in Japanese subjects. J Atheroscler Thromb, 2009; 16: 782-791
16. Finn AV, Kolodgie FD, Virmani R: Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. Arterioscler Thromb Vasc Biol, 2010; 30: 177-81
17. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN; REVERSAL Investigators: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA, 2004; 291: 1071-1080
18. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM; ASTEROID Investigators: Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA, 2006; 295: 1556-1565
19. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, Daida H: Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation, 2004; 110: 1061-1068
20. Underhill HR, Yuan C, Zhao XQ, Kraiss LW, Parker DL, Saam T, Chu B, Takaya N, Liu F, Polissar NL, Neradilek B, Raichlen JS, Cain VA, Waterton JC, Hamar W, Hatsukami TS: Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Am Heart J, 2008; 155: 584-588
21. Crouse JR, III, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS; Measuring Effects on intima media Thickness: an Evalution Of Rosuvastatin study group. Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study. Cardiovasc Drugs Ther, 2004; 18: 231-238
22. Crouse JR, III, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML; METEOR Study Group: Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA, 2007; 297: 1344-1353
23. Crouse JR, III, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS; METEOR Study Group: Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study. Curr Med Res Opin, 2007; 23: 641-648
24. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M: Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc, 2007; 23: 75-80
25. Arai H, Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, Yamaguchi T, Daida H, Matsuzaki M; JAPAN-ACS Investigators: More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study. J Atheroscler Thromb, 2010; 17: 1096-1107
26. Ballantyne CM, Raichlen JS, Nicholls SJ, Erbel R, Tardif JC, Brener SJ, Cain VA, Nissen SE; ASTEROID Investigators: Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation, 2008; 117: 2458-2466
27. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Smith D, Weinberger J, Wentzel J, Mizsei G, Mercuri M, Badimon JJ: Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation, 2002; 106: 2884-2887
28. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Chaplin WF, Muntwyler J, Viles-Gonzalez JF, Weinberger J, Smith DA, Mizsei G, Badimon JJ: Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol, 2005; 46: 106-112
29. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, Yamaguchi T, Daida H, Matsuzaki M; JAPAN-ACS Investigators: Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol, 2009; 54: 293-302
30. Kurabayashi M, Sakuma I, Kawamori R, Daida H, Yamazaki T, Yoshida M, Hata M, Masuda I, Kaku K, Yokoi H, Kishimoto J, Nohara R: Can intensive lipidlowering therapy with statins ameliorate atherosclerosis in Japanese patients? Rationale and design of the JART study. J Atheroscler Thromb, 2010; 17: 416-422
31. Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD: 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke, 2005; 36: 1904-1909
32. Krasinski A, Chiu B, Spence JD, Fenster A, Parraga G: Three-dimensional ultrasound quantification of intensive statin treatment of carotid atherosclerosis. Ultrasound Med Biol, 2009; 35: 1763-1772
33. Rothman KJ, Greenland S: Modern epidemiology. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 1998
34. Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, Virmani R: Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation, 2001; 103: 934-940
35. Polak JF, Shemanski L, O'Leary DH, Lefkowitz D, Price TR, Savage PJ, Brant WE, Reid C: Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study. Radiology, 1998; 208: 649-654
36. Sabetai MM, Tegos TJ, Nicolaides AN, El-Atrozy TS, Dhanjil S, Griffin M, Belcaro G, Geroulakos G: Hemispheric symptoms and carotid plaque echomorphology. J Vasc Surg, 2000; 31(1 Pt 1): 39-49
37. Verhoeven B, Hellings WE, Moll FL, de Vries JP, de Kleijn DP, de Bruin P, Busser E, Schoneveld AH, Pasterkamp G: Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients. J Vasc Surg, 2005; 42: 1075-1081